Global Ocular Drug Delivery System Market Research Report 2024

Publication ID:

PB503242534

Publication Date:

March 11, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Ocular drug delivery system designed to treat eye locally, whereas the conventional method of drug delivery is less effective due to the presence of various barriers.
The global Ocular Drug Delivery System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery System.
Report Scope
The Ocular Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ocular Therapeutix
Alimera Sciences
Allergan
Graybug Vision
Bausch Health
EyePoint Pharmaceuticals
Santen Pharmaceutical
Taiwan Liposome
Envisia Therapeutics
Clearside Biomedical
Segment by Type
Implantable Ocular Drug Delivery Systems
Particulate Drug Delivery Systems
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ocular Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Ocular Drug Delivery System Market Overview
1.1 Product Overview and Scope of Ocular Drug Delivery System
1.2 Ocular Drug Delivery System Segment by Type
1.2.1 Global Ocular Drug Delivery System Market Value Comparison by Type (2024-2030)
1.2.2 Implantable Ocular Drug Delivery Systems
1.2.3 Particulate Drug Delivery Systems
1.3 Ocular Drug Delivery System Segment by Application
1.3.1 Global Ocular Drug Delivery System Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Ocular Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Ocular Drug Delivery System Revenue 2019-2030
1.4.2 Global Ocular Drug Delivery System Sales 2019-2030
1.4.3 Global Ocular Drug Delivery System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ocular Drug Delivery System Market Competition by Manufacturers
2.1 Global Ocular Drug Delivery System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ocular Drug Delivery System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ocular Drug Delivery System Average Price by Manufacturers (2019-2024)
2.4 Global Ocular Drug Delivery System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ocular Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ocular Drug Delivery System, Product Type & Application
2.7 Ocular Drug Delivery System Market Competitive Situation and Trends
2.7.1 Ocular Drug Delivery System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Ocular Drug Delivery System Players Market Share by Revenue
2.7.3 Global Ocular Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ocular Drug Delivery System Retrospective Market Scenario by Region
3.1 Global Ocular Drug Delivery System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ocular Drug Delivery System Global Ocular Drug Delivery System Sales by Region: 2019-2030
3.2.1 Global Ocular Drug Delivery System Sales by Region: 2019-2024
3.2.2 Global Ocular Drug Delivery System Sales by Region: 2025-2030
3.3 Global Ocular Drug Delivery System Global Ocular Drug Delivery System Revenue by Region: 2019-2030
3.3.1 Global Ocular Drug Delivery System Revenue by Region: 2019-2024
3.3.2 Global Ocular Drug Delivery System Revenue by Region: 2025-2030
3.4 North America Ocular Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ocular Drug Delivery System Sales by Country (2019-2030)
3.4.3 North America Ocular Drug Delivery System Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ocular Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ocular Drug Delivery System Sales by Country (2019-2030)
3.5.3 Europe Ocular Drug Delivery System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ocular Drug Delivery System Market Facts & Figures by Country
3.6.1 Asia Pacific Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ocular Drug Delivery System Sales by Country (2019-2030)
3.6.3 Asia Pacific Ocular Drug Delivery System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ocular Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ocular Drug Delivery System Sales by Country (2019-2030)
3.7.3 Latin America Ocular Drug Delivery System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ocular Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Ocular Drug Delivery System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ocular Drug Delivery System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ocular Drug Delivery System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ocular Drug Delivery System Sales by Type (2019-2030)
4.1.1 Global Ocular Drug Delivery System Sales by Type (2019-2024)
4.1.2 Global Ocular Drug Delivery System Sales by Type (2025-2030)
4.1.3 Global Ocular Drug Delivery System Sales Market Share by Type (2019-2030)
4.2 Global Ocular Drug Delivery System Revenue by Type (2019-2030)
4.2.1 Global Ocular Drug Delivery System Revenue by Type (2019-2024)
4.2.2 Global Ocular Drug Delivery System Revenue by Type (2025-2030)
4.2.3 Global Ocular Drug Delivery System Revenue Market Share by Type (2019-2030)
4.3 Global Ocular Drug Delivery System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ocular Drug Delivery System Sales by Application (2019-2030)
5.1.1 Global Ocular Drug Delivery System Sales by Application (2019-2024)
5.1.2 Global Ocular Drug Delivery System Sales by Application (2025-2030)
5.1.3 Global Ocular Drug Delivery System Sales Market Share by Application (2019-2030)
5.2 Global Ocular Drug Delivery System Revenue by Application (2019-2030)
5.2.1 Global Ocular Drug Delivery System Revenue by Application (2019-2024)
5.2.2 Global Ocular Drug Delivery System Revenue by Application (2025-2030)
5.2.3 Global Ocular Drug Delivery System Revenue Market Share by Application (2019-2030)
5.3 Global Ocular Drug Delivery System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ocular Therapeutix
6.1.1 Ocular Therapeutix Corporation Information
6.1.2 Ocular Therapeutix Description and Business Overview
6.1.3 Ocular Therapeutix Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ocular Therapeutix Ocular Drug Delivery System Product Portfolio
6.1.5 Ocular Therapeutix Recent Developments/Updates
6.2 Alimera Sciences
6.2.1 Alimera Sciences Corporation Information
6.2.2 Alimera Sciences Description and Business Overview
6.2.3 Alimera Sciences Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alimera Sciences Ocular Drug Delivery System Product Portfolio
6.2.5 Alimera Sciences Recent Developments/Updates
6.3 Allergan
6.3.1 Allergan Corporation Information
6.3.2 Allergan Description and Business Overview
6.3.3 Allergan Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Allergan Ocular Drug Delivery System Product Portfolio
6.3.5 Allergan Recent Developments/Updates
6.4 Graybug Vision
6.4.1 Graybug Vision Corporation Information
6.4.2 Graybug Vision Description and Business Overview
6.4.3 Graybug Vision Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Graybug Vision Ocular Drug Delivery System Product Portfolio
6.4.5 Graybug Vision Recent Developments/Updates
6.5 Bausch Health
6.5.1 Bausch Health Corporation Information
6.5.2 Bausch Health Description and Business Overview
6.5.3 Bausch Health Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bausch Health Ocular Drug Delivery System Product Portfolio
6.5.5 Bausch Health Recent Developments/Updates
6.6 EyePoint Pharmaceuticals
6.6.1 EyePoint Pharmaceuticals Corporation Information
6.6.2 EyePoint Pharmaceuticals Description and Business Overview
6.6.3 EyePoint Pharmaceuticals Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 EyePoint Pharmaceuticals Ocular Drug Delivery System Product Portfolio
6.6.5 EyePoint Pharmaceuticals Recent Developments/Updates
6.7 Santen Pharmaceutical
6.6.1 Santen Pharmaceutical Corporation Information
6.6.2 Santen Pharmaceutical Description and Business Overview
6.6.3 Santen Pharmaceutical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Santen Pharmaceutical Ocular Drug Delivery System Product Portfolio
6.7.5 Santen Pharmaceutical Recent Developments/Updates
6.8 Taiwan Liposome
6.8.1 Taiwan Liposome Corporation Information
6.8.2 Taiwan Liposome Description and Business Overview
6.8.3 Taiwan Liposome Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taiwan Liposome Ocular Drug Delivery System Product Portfolio
6.8.5 Taiwan Liposome Recent Developments/Updates
6.9 Envisia Therapeutics
6.9.1 Envisia Therapeutics Corporation Information
6.9.2 Envisia Therapeutics Description and Business Overview
6.9.3 Envisia Therapeutics Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Envisia Therapeutics Ocular Drug Delivery System Product Portfolio
6.9.5 Envisia Therapeutics Recent Developments/Updates
6.10 Clearside Biomedical
6.10.1 Clearside Biomedical Corporation Information
6.10.2 Clearside Biomedical Description and Business Overview
6.10.3 Clearside Biomedical Ocular Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Clearside Biomedical Ocular Drug Delivery System Product Portfolio
6.10.5 Clearside Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ocular Drug Delivery System Industry Chain Analysis
7.2 Ocular Drug Delivery System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ocular Drug Delivery System Production Mode & Process
7.4 Ocular Drug Delivery System Sales and Marketing
7.4.1 Ocular Drug Delivery System Sales Channels
7.4.2 Ocular Drug Delivery System Distributors
7.5 Ocular Drug Delivery System Customers
8 Ocular Drug Delivery System Market Dynamics
8.1 Ocular Drug Delivery System Industry Trends
8.2 Ocular Drug Delivery System Market Drivers
8.3 Ocular Drug Delivery System Market Challenges
8.4 Ocular Drug Delivery System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Ocular Therapeutix
Alimera Sciences
Allergan
Graybug Vision
Bausch Health
EyePoint Pharmaceuticals
Santen Pharmaceutical
Taiwan Liposome
Envisia Therapeutics
Clearside Biomedical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂